— Know what they know.
Not Investment Advice

RXEI OTC

RxElite, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -75.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $1483 mcap · 12M float · 0.0016% daily turnover

Income Trends

Revenue
$3M +139.0% ▲
3Y CAGR: +49.9%
Gross Profit
$144K -80.6% ▼
3Y CAGR: -44.3%
Operating Income
$12M +8429.3% ▲
3Y CAGR: +145.0%
Net Income
-$17M -18363.7% ▼
EPS (Diluted)
$-0.27 -3100.0% ▼
EBITDA
-$16M -10548.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2004FY2005FY2006FY2007
Revenue$835K$966K$1M$3M
YoY Growth+0.0%+15.7%+21.7%+139.0%
Cost of Revenue$0$449K$435K$3M
Gross Profit$835K$517K$742K$144K
Gross Margin100.0%53.5%63.1%5.1%
R&D Expenses$0$0$0$3M
SG&A Expenses$0$553K$598K$9M
Operating Expenses$0$553K$598K$12M
Operating Income$835K$36K$144K$12M
Operating Margin100.0%3.7%12.2%436.8%
Interest Expense$0$0$0$0
Income Before Tax$0$0$144K-$17M
Tax Expense$34K$0$50K$5M
Net Income-$34K-$36K$94K-$17M
Net Margin-4.1%-3.7%8.0%-610.5%
EPS (Diluted)$0.00$-0.00$0.01$-0.27
EBITDA$835K-$29K$158K-$16M
Shares Outstanding010M10M62M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms